A case of doxorubicin and cyclophosphamide therapy-induced type 1 diabetes: a case report

Abstract Background Patients receiving immune checkpoint inhibitors have been reported to develop autoimmune endocrine diseases, including type 1 diabetes, although few drugs have been shown to induce type 1 diabetes. Additionally, it is important to note that drugs other than immune checkpoint inhi...

Full description

Bibliographic Details
Main Authors: Makoto Miyabayashi, Shunichiro Onishi, Tomohiko Yoshida, Minoru Takemoto
Format: Article
Language:English
Published: BMC 2023-01-01
Series:Journal of Medical Case Reports
Subjects:
Online Access:https://doi.org/10.1186/s13256-023-03755-x